Page last updated: 2024-08-16

tibolone and Cancer of the Uterus

tibolone has been researched along with Cancer of the Uterus in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (27.59)18.2507
2000's19 (65.52)29.6817
2010's2 (6.90)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cancelo Hidalgo, MJ1
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS1
Neves-E-Castro, M1
Carranza Lira, S1
Schindler, AE1
Karakus, C; Simsek, T; Trak, B1
Göçmen, A; Kara, IH; Karaca, M1
De Falco, M; De Rosa, G; Di Lieto, A; Mansueto, G; Pollio, F; Staibano, S1
Lethaby, A; Vollenhoven, B2
Ciociola, F; De Falco, M; Di Lieto, A; Mansueto, G; Pollio, F; Pontillo, M; Salvatore, G; Staibano, S1
Busiello, A; Carbone, IF; D'Armiento, FP; De Falco, M; Di Lieto, A; Mascolo, M; Pollio, F; Salvatore, G; Staibano, S1
Fogelman, I; Morris, EP; Robinson, J; Rymer, J1
Lethaby, AE; Vollenhoven, BJ1
Falbo, A; Oppedisano, R; Orio, F; Palomba, S; Tolino, A; Zullo, F1
Davies, AP; Oram, D1
Bennink, HJ; Kicovic, P; Lindsay, PC; Shaw, RW1
Ginsburg, J; Prelevic, GM1
Chryssikopoulos, A; Costomenos, D; Gregoriou, O; Konidaris, S; Papadias, C; Vitoratos, N1
Affinito, P; Nappi, C; Palomba, S; Tommaselli, GA1
Altieri, P; de Aloysio, D; Penacchioni, P; Salgarello, M; Ventura, V1
Affinito, P; Bifulco, G; Di Carlo, C; Nappi, C; Palomba, S1
Bianchi, S; Fedele, L; Raffaelli, R; Zanconato, G1
D'Altorio, C; Di Biase, S; Lanzilotti, G; Orsini, G; Pinto, V1
Affinito, P; Di Carlo, C; Nappi, C; Palomba, S; Pellicano, M; Zullo, F1
Botsis, D; Creatsas, G; Gregoriou, O; Konidaris, S; Makrakis, E; Papadias, C1
Ang, WC; Farrell, E; Vollenhoven, B1
Mastrantonio, P; Morelli, M; Noia, R; Oliverio, A; Palomba, S; Santagata, M; Sena, T; Zullo, F1
Di Carlo, C; Morelli, M; Noia, R; Palomba, S; Pellicano, M; Zullo, F1

Reviews

8 review(s) available for tibolone and Cancer of the Uterus

ArticleYear
[Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].
    Medicina clinica, 2013, Volume: 141 Suppl 1

    Topics: Combined Modality Therapy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hysterectomy; Leiomyoma; Levonorgestrel; Norpregnenes; Progesterone; Progestins; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms

2013
Add-back therapy with GnRH analogues for uterine fibroids.
    The Cochrane database of systematic reviews, 2015, Mar-20, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms

2015
Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
    Clinical obstetrics and gynecology, 2008, Volume: 51, Issue:3

    Topics: Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms

2008
[Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth].
    Ginecologia y obstetricia de Mexico, 2008, Volume: 76, Issue:10

    Topics: Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Uterine Neoplasms

2008
Fibroids (uterine myomatosis, leiomyomas).
    Clinical evidence, 2004, Issue:12

    Topics: Antineoplastic Agents, Hormonal; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysterectomy, Vaginal; Leiomyoma; Norpregnenes; Progestins; Uterine Neoplasms

2004
Fibroids (uterine myomatosis, leiomyomas).
    American family physician, 2005, May-01, Volume: 71, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Diagnosis, Differential; Drug Therapy, Combination; Estrogen Receptor Modulators; Female; Gynecologic Surgical Procedures; Humans; Laparoscopy; Leiomyoma; Leiomyomatosis; Leuprolide; Norpregnenes; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Uterine Neoplasms

2005
An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Best practice & research. Clinical obstetrics & gynaecology, 2008, Volume: 22, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estrogen Antagonists; Evidence-Based Medicine; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Premenopause; Progestins; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Neoplasms

2008
Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
    Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:4

    Topics: Animals; Disease Models, Animal; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms

2001

Trials

18 trial(s) available for tibolone and Cancer of the Uterus

ArticleYear
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
    Maturitas, 2002, Jul-25, Volume: 42, Issue:3

    Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Polyps; Postmenopause; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms

2002
The effects of add-back therapy with tibolone on myoma uteri.
    Clinical and experimental obstetrics & gynecology, 2002, Volume: 29, Issue:3

    Topics: Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Prospective Studies; Treatment Outcome; Triptorelin Pamoate; Ultrasonography; Uterine Neoplasms

2002
Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern.
    Steroids, 2005, Volume: 70, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Female; Fibroblast Growth Factor 2; Gonadotropin-Releasing Hormone; Humans; Immunohistochemistry; Leiomyoma; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Norpregnenes; Platelet-Derived Growth Factor; Premenopause; Uterine Neoplasms; Uterus; Vascular Endothelial Growth Factor A

2005
Expression of proliferating cell nuclear antigen and bcl-2 during a pseudomenopausal state induced by presurgical treatment of uterine leiomyomas with gonadotropin-releasing hormone analogues plus tibolone.
    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2005, Volume: 24, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Leiomyoma; Leuprolide; Norpregnenes; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Uterine Neoplasms

2005
Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
    Journal of the Society for Gynecologic Investigation, 2006, Volume: 13, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Bone Density; Connective Tissue Growth Factor; Drug Therapy, Combination; Female; Hemoglobins; Hot Flashes; Humans; Immediate-Early Proteins; Immunohistochemistry; Injections, Subcutaneous; Intercellular Signaling Peptides and Proteins; Iron; Leiomyoma; Leuprolide; Myometrium; Neoadjuvant Therapy; Norpregnenes; Transforming Growth Factor beta; Transforming Growth Factor beta3; Uterine Neoplasms

2006
Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Fertility and sterility, 2008, Volume: 89, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Bone and Bones; Bone Density; Chemotherapy, Adjuvant; Cross-Over Studies; Double-Blind Method; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Middle Aged; Norpregnenes; Patient Compliance; Placebos; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms

2008
Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
    Fertility and sterility, 2008, Volume: 90, Issue:1

    Topics: Administration, Oral; Adult; Affect; Antineoplastic Agents, Hormonal; Central Nervous System Agents; Cognition; Delayed-Action Preparations; Female; Humans; Leiomyoma; Leuprolide; Middle Aged; Norpregnenes; Quality of Life; Single-Blind Method; Time Factors; Treatment Outcome; Uterine Neoplasms

2008
The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
    Fertility and sterility, 1996, Volume: 65, Issue:2

    Topics: Adult; Anabolic Agents; Bone Density; Double-Blind Method; Drug Interactions; Endometriosis; Female; Humans; Leiomyoma; Luteolytic Agents; Norpregnenes; Prospective Studies; Triptorelin Pamoate; Uterine Neoplasms

1996
Effect of tibolone on postmenopausal women with myomas.
    Maturitas, 1997, Volume: 27, Issue:2

    Topics: Anabolic Agents; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Ultrasonography; Uterine Neoplasms

1997
A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
    Fertility and sterility, 1998, Volume: 70, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers; Bone and Bones; Bone Density; Climacteric; Double-Blind Method; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Lipids; Muscle, Smooth, Vascular; Norpregnenes; Prospective Studies; Ultrasonography; Uterine Neoplasms

1998
Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
    Maturitas, 1998, Jun-17, Volume: 29, Issue:3

    Topics: Anabolic Agents; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Uterine Neoplasms

1998
Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles.
    Fertility and sterility, 1999, Volume: 72, Issue:5

    Topics: Adult; Antineoplastic Agents, Hormonal; Bone Density; Endometrium; Endosonography; Female; Gonadotropin-Releasing Hormone; Humans; Hysteroscopy; Leiomyoma; Lipid Metabolism; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms; Vasomotor System

1999
A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
    European journal of obstetrics, gynecology, and reproductive biology, 2000, Volume: 88, Issue:1

    Topics: Administration, Cutaneous; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Norpregnenes; Progesterone Congeners; Treatment Outcome; Uterine Neoplasms

2000
[The effects of menopausal replacement therapy in women with uterine myomas].
    Minerva ginecologica, 1999, Volume: 51, Issue:11

    Topics: Antineoplastic Agents, Hormonal; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norpregnenes; Time Factors; Uterine Neoplasms

1999
Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy.
    Fertility and sterility, 2001, Volume: 75, Issue:2

    Topics: Adult; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Iron; Laparoscopy; Leiomyoma; Leuprolide; Norpregnenes; Placebos; Prospective Studies; Treatment Outcome; Uterine Neoplasms

2001
Long term effects of Tibolone on postmenopausal women with uterine myomas.
    Maturitas, 2001, Oct-31, Volume: 40, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Female; Humans; Leiomyoma; Middle Aged; Norpregnenes; Postmenopause; Pulsatile Flow; Time; Treatment Outcome; Ultrasonography; Uterine Neoplasms; Uterus

2001
Short-term administration of tibolone plus GnRH analog before laparoscopic myomectomy.
    The Journal of the American Association of Gynecologic Laparoscopists, 2002, Volume: 9, Issue:2

    Topics: Adult; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Leiomyoma; Middle Aged; Norpregnenes; Preoperative Care; Prospective Studies; Uterine Neoplasms

2002
Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone.
    Fertility and sterility, 2002, Volume: 78, Issue:1

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density; Bone Development; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Postmenopause; Prospective Studies; Reference Values; Uterine Neoplasms

2002

Other Studies

3 other study(ies) available for tibolone and Cancer of the Uterus

ArticleYear
The value of gonadotropin-releasing hormone-agonists together with other drugs for medical treatment and prevention.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2009, Volume: 25, Issue:12

    Topics: Drug Therapy, Combination; Endometriosis; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Uterine Neoplasms

2009
Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125.
    British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:7

    Topics: Antigens, Tumor-Associated, Carbohydrate; Diagnosis, Differential; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Uterine Neoplasms

1994
Cause of vaginal bleeding in postmenopausal women taking tibolone.
    Maturitas, 1996, Volume: 24, Issue:1-2

    Topics: Aged; Aged, 80 and over; Anabolic Agents; Carcinoma in Situ; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hysteroscopy; Leiomyoma; Middle Aged; Norpregnenes; Polyps; Postmenopause; Time Factors; Ultrasonography, Doppler; Uterine Hemorrhage; Uterine Neoplasms

1996